|
India revokes patent on Merck & Co asthma drug
Reuters MUMBAI (Reuters) – India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co, citing lack of invention, after Indian drugmaker Cipla Ltd challenged an earlier decision. The move is the latest in a … |
View full post on asthma – Google News